ITM to Present at the 43rd Annual J.P. Morgan Healthcare Conference
December 13, 2024 05:00 ET
|
ITM Isotope Technologies Munich SE
Garching / Munich, Germany, December 13, 2024 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced that its Chief Executive Officer, Dr. Andrew...
Saudi Arabia Radiotherapy Markets, Competition, Forecast & Opportunities, 2029, Profiles of Key Players - Gulf Medical, Siemens Industrial, Almana Group of Hospitals, and Varian Medical
November 21, 2024 10:57 ET
|
Research and Markets
Dublin, Nov. 21, 2024 (GLOBE NEWSWIRE) -- The "Saudi Arabia Radiotherapy Market, By Region, Competition, Forecast & Opportunities, 2019-2029F" report has been added to ResearchAndMarkets.com's...
Metastatic Colorectal Cancer Market Forecast to Reach US$ 9,787.5 Million by 2034, Growing at 5.1% CAGR | Fact.MR Report
November 20, 2024 07:30 ET
|
FACT.MR
Rockville, MD, Nov. 20, 2024 (GLOBE NEWSWIRE) -- According to Fact.MR, a market research and competitive intelligence provider, the global metastatic colorectal cancer market is estimated to reach a...
Radiation Oncology Market Size to Hit USD 28.07 Billion by 2033 | Straits Research
November 11, 2024 10:20 ET
|
Straits Research Private Limited - Garner Insights
New York, United States , Nov. 11, 2024 (GLOBE NEWSWIRE) -- Radiation oncology (radiotherapy/radiotherapy) is a medical specialty that must be incorporated into interdisciplinary cancer treatment...
ITM to Participate in Upcoming Investor Conferences
November 11, 2024 05:00 ET
|
ITM Isotope Technologies Munich SE
Garching / Munich, November 11, 2024 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced its participation in two upcoming industry investor...
ITM, TUM und das TUM Universitätsklinikum unterzeichnen eine neue Rahmenvereinbarung zur Entwicklung innovativer radiopharmazeutischer Krebstherapien
October 24, 2024 05:00 ET
|
ITM Isotope Technologies Munich SE
Neufahrn / Garching / München, 24. Oktober 2024 – ITM Isotope Technologies Munich SE (ITM), ein führendes radiopharmazeutisches Unternehmen, die Technische Universität München (TUM) und das TUM...
ITM, TUM, and TUM University Hospital Sign New Framework Agreement to Advance Innovative Radiopharmaceutical Cancer Treatments
October 24, 2024 05:00 ET
|
ITM Isotope Technologies Munich SE
Neufahrn / Garching / Munich, Germany, October 24, 2024 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, the Technical University of Munich (TUM) and the TUM...
ITM and NTP Strengthen Global Radioisotope Production Capacities by Renewing their Technology License Agreement and Signing a Manufacturing and Supply Agreement for n.c.a. Lutetium-177
October 18, 2024 05:00 ET
|
ITM Isotope Technologies Munich SE
Extension of 2012 agreement grants NTP the rights to manufacture and distribute non-carrier-added Lutetium-177 (n.c.a. 177Lu)Companies enter into an additional manufacturing and supply...
Radiotherapy Market Analysis and Forecast 2018-2030: China and India Witnessing Substantial Market Growth Due to Their Large Population Base and Efforts to Improve Cancer Treatment Facilities
October 03, 2024 04:20 ET
|
Research and Markets
Dublin, Oct. 03, 2024 (GLOBE NEWSWIRE) -- The Radiotherapy Market (By Technology, Procedure, Application, End User, Country Analysis), Company Profiles, Market Dynamics, Trends & Recent...
Radiopharmaceuticals Market to hit USD 15.4 billion by 2032, says Global Market Insights Inc.
October 01, 2024 04:30 ET
|
Global Market Insights Inc.
Selbyville, Delaware, Oct. 01, 2024 (GLOBE NEWSWIRE) -- Radiopharmaceuticals Market size was valued at USD 6.7 billion in 2023 and is expected to grow at a CAGR of 9.8% over the forecast...